AI assistant
SENSIENT TECHNOLOGIES CORP — Director's Dealing 2011
Mar 4, 2011
31054_dirs_2011-03-04_d37ce020-f6ad-4654-ba83-434de5c381be.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SENSIENT TECHNOLOGIES CORP (SXT)
CIK: 0000310142
Period of Report: 2011-03-03
Reporting Person: CROFT JAMES AD (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-03-03 | Common Stock | M | 2000 | $25.19 | Acquired | 22464.967 | Direct |
| 2011-03-03 | Common Stock | M | 2000 | $26.12 | Acquired | 24464.967 | Direct |
| 2011-03-03 | Common Stock | S | 4000 | $33.7766 | Disposed | 20464.967 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-03-03 | Stock Options (Right to Buy) | $25.19 | M | 2000 | Disposed | 2012-05-01 | Common Stock (2000) | Direct |
| 2011-03-03 | Stock Options (Right to Buy) | $26.12 | M | 2000 | Disposed | 2017-05-01 | Common Stock (2000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1500 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $30.07 | 2018-05-01 | Common Stock (2000) | 2000 | Direct |
Footnotes
F1: Exercise of in-the-money stock option that would otherwise expire on 5/1/2012, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
F2: Includes shares of restricted stock held under Issuer's 2002 Non-Employee Director Stock Plan and shares held in a dividend reinvestment plan.
F3: Exercise of in-the-money stock option that would otherwise expire on 5/1/2017, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
F4: This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $33.76 to $33.80. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F5: Original option grant vests in three equal annual installments beginning on the date listed in the "Date Exercisable" column.